RA PHARMACEUTICALS, INC. Net Cash Provided by (Used in) Continuing Operations
RA PHARMACEUTICALS, INC. reported Net Cash Provided by (Used in) Continuing Operations of -$12.44 million for the 3-month period ending 2017-03-31, per its 10-Q filed 2017-05-11.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:NetCashProvidedByUsedInContinuingOperations · last filed 2017-05-11
- RA PHARMACEUTICALS, INC. net cash provided by (used in) continuing operations for the quarter ending 2017-03-31 was -$12.44M.
- RA PHARMACEUTICALS, INC. net cash provided by (used in) continuing operations for the quarter ending 2016-12-31 was $86.62M.
- RA PHARMACEUTICALS, INC. net cash provided by (used in) continuing operations for the quarter ending 2016-03-31 was -$5.70M.
- RA PHARMACEUTICALS, INC. net cash provided by (used in) continuing operations for the quarter ending 2015-12-31 was -$3.03M.
- RA PHARMACEUTICALS, INC. net cash provided by (used in) continuing operations for fiscal 2016 was $98.43M, a 541.34% increase from fiscal 2015.
- RA PHARMACEUTICALS, INC. net cash provided by (used in) continuing operations for fiscal 2015 was $15.35M, a 5626.49% increase from fiscal 2014.
- RA PHARMACEUTICALS, INC. net cash provided by (used in) continuing operations for fiscal 2014 was $268.00K.
| Period end | Net Cash Provided by (Used in) Continuing Operations 3 month | Net Cash Provided by (Used in) Continuing Operations 6 month | Net Cash Provided by (Used in) Continuing Operations 9 month | Net Cash Provided by (Used in) Continuing Operations 12 month |
|---|---|---|---|---|
| 2017-03-31 | -$12.44M 10-Q · filed 2017-05-11 | $74.18M derived: sum of 2 quarters · filed 2017-05-11 | ||
| 2016-12-31 | $86.62M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-06 | $98.43M 10-K · filed 2017-03-06 | ||
| 2016-09-30 | $11.81M 10-Q · filed 2016-11-29 | |||
| 2016-03-31 | -$5.70M 10-Q · filed 2017-05-11 | -$8.74M derived: sum of 2 quarters · filed 2017-05-11 | ||
| 2015-12-31 | -$3.03M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-06 | $15.35M 10-K · filed 2017-03-06 | ||
| 2015-09-30 | $18.38M 10-Q · filed 2016-11-29 | |||
| 2014-12-31 | $268.00K 10-K · filed 2017-03-06 |